Even attenuated bovine leukemia virus proviruses can be pathogenic in sheep

Journal of Virology

Volumn 81, Issue 18, 2007, Pages 10195-10200

  Florins, Arnaud ^a   Gillet, Nicolas ^a   Boxus, Mathieu ^a   Kerkhofs, Pierre ^b   Kettmann, Richard ^a   Willems, Luc ^a,c  

^a Molecular and Cellular Biology   (Belgium)

^b VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^c FUND FOR SCIENTIFIC RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOVINE LEUKEMIA VIRUS; CARCINOGENESIS; CONTROLLED STUDY; GENE MUTATION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROVIRUS; SEQUENCE ANALYSIS; SHEEP; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; VIRUS INFECTION; WILD TYPE; ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; GENE DELETION; GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; SHEEP DISEASE; TIME; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS LATENCY;

BOVINE LEUKEMIA VIRUS; OVIS ARIES;

AMINO ACID MOTIFS; ANIMALS; CATTLE; CELL TRANSFORMATION, VIRAL; DNA MUTATIONAL ANALYSIS; ENZOOTIC BOVINE LEUKOSIS; LEUKEMIA VIRUS, BOVINE; LYMPHOMA; MEMBRANE PROTEINS; SEQUENCE DELETION; SHEEP; SHEEP DISEASES; TIME FACTORS; VIRAL PROTEINS; VIRUS LATENCY;

EID: 35348858951     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01058-07     Document Type: Article

References (39)

1. Baba, T. W., Y. S. Jeong, D. Pennick, R. Branson, M. F. Greene, and R. M. Ruprecht. 1995. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820-1825.
2. Baba, T. W., V. Liska, A. H. Khimani, N. B. Ray, P. J. Dailey, D. Penninck, R. Branson, M. F. Greene, H. M. McClure, L. N. Martin, and R. M. Ruprecht. 1999. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med. 5:194-203.
3. Bartoe, J. T., B. Albrecht, N. D. Collins, M. D. Robek, L. Ratner, P. L. Green, and M. D. Lairmore. 2000. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 74:1094-1100.
4. Collins, N. D., G. C. Newbound, B. Albrecht, J. L. Beard, L. Ratner, and M. D. Lairmore. 1998. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 91:4701-4707.
5. Debacq, C., M. T. Sanchez Alcaraz, F. Mortreux, P. Kerkhofs, R. Kettmann, and L. Willems. 2004. Reduced proviral loads during primo-infection of sheep by bovine leukemia virus attenuated mutants. Retrovirology 1:31.
6. Dequiedt, F., R. Kettmann, A. Burny, and L. Willems. 1995. Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep. Virology 209:676-683.
7. Florins, A., N. Gillet, B. Asquith, M. Boxus, C. Burteau, J. C. Twizere, P. Urbain, F. Vandermeers, C. Debacq, M. T. Sanchez-Alcaraz, I. Schwartz-Cornil, P. Kerkhofs, G. Jean, A. Thewis, J. Hay, F. Mortreux, E. Wattel, M. Reichert, A. Burny, R. Kettmann, C. Bangham, and L. Willems. 2007. Cell dynamics and immune response to BLV infection: a unifying model. Front. Biosci. 12:1520-1531.
8. Furukawa, Y., K. Usuku, S. Izumo, and M. Osame. 2004. Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo. AIDS Res. Hum. Retrovir. 20:1092-1099.
9. Gallo, R. C. 2005. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 24:5926-5930.
10. Gatot, J. S., I. Callebaut, J. P. Mornon, D. Portetelle, A. Burny, P. Kerkhofs, R. Kettmann, and L. Willems. 1998. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo. J. Biol. Chem. 273:12870- 12880.
11. Gillet, N., A. Florins, M. Boxus, C. Burteau, A. Nigro, F. Vandermeers, H. Balon, A. B. Bouzar, J. Defoiche, A. Burny, M. Reichert, R. Kettmann, and L. Willems. 2007. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology 4:18.
12. Hofmann-Lehmann, R., J. Vlasak, A. L. Williams, A. L. Chenine, H. M. McClure, D. C. Anderson, S. O'Neil, and R. M. Ruprecht. 2003. Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS 17:157-166.
13. Iniguez, A. M., R. Gastaldello, S. Gallego, K. Otsuki, and A. C. Vicente. 2006. HTLV-1 p12I protein sequences from South America: truncated proteins and common genetic signatures. AIDS Res. Hum. Retrovir. 22:466-469.
14. Kerkhofs, P., J. S. Gatot, K. Knapen, M. Mammerickx, A. Burny, D. Portetelle, L. Willems, and R. Kettmann. 2000. Long-term protection against bovine leukaemia virus replication in cattle and sheep. J. Gen. Virol. 81:957-963.
15. Kerkhofs, P., H. Heremans, A. Burny, R. Kettmann, and L. Willems. 1998. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J. Virol. 72:2554-2559.
16. Kettmann, R., J. Deschamps, Y. Cleuter, D. Couez, A. Burny, and G. Marbaix. 1982. Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3′ proximate cellular sequences. Proc. Natl. Acad. Sci. USA 79:2465-2469.
17. Lefebvre, L., A. Vanderplasschen, V. Ciminale, H. Heremans, O. Dangoisse, J. C. Jauniaux, J. F. Toussaint, V. Zelnik, A. Burny, R. Kettmann, and L. Willems. 2002. Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J. Virol. 76:1400-1414.
18. Lew, A. E., R. E. Bock, J. B. Molloy, C. M. Minchin, S. J. Robinson, and P. Steer. 2004. Sensitive and specific detection of proviral bovine leukemia virus by 5′ Taq nuclease PCR using a 3′ minor groove binder fluorogenic probe. J. Virol. Methods 115:167-175.
19. Merezak, C., C. Pierreux, E. Adam, F. Lemaigre, G. G. Rousseau, C. Calomme, C. Van Lint, D. Christophe, P. Kerkhofs, A. Burny, R. Kettmann, and L. Willems. 2001. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J. Virol. 75:6977-6988.
20. Moules, V., C. Pomier, D. Sibon, A. S. Gabet, M. Reichert, P. Kerkhofs, L. Willems, F. Mortreux, and E. Wattel. 2005. Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy. Cancer Res. 65:1234-1243.
21. Philpott, S. M., and G. C. Buehring. 1999. Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene. J. Natl. Cancer Inst. 91:933-942.
22. Reichert, M., G. H. Cantor, L. Willems, and R. Kettmann. 2000. Protective effects of a live attenuated bovine leukaemia virus vaccine with deletion in the R3 and G4 genes. J. Gen. Virol. 81:965-969.
23. Rice, N., and R. G. R. Stephens. 1987. Sequence analysis of the bovine leukemia virus genome, p. 115-144. In A. Burny and M. Mammerickx (ed.), Enzootic bovine leukosis and bovine leukemia virus. Nijhoff, The Hague, The Netherlands.
24. Ruprecht, R. M. 1999. Live attenuated AIDS viruses as vaccines: promise or peril? Immunol. Rev. 170:135-149.
25. Schnurr, M. W., R. F. Carter, I. D. Dube, V. E. Valli, and R. M. Jacobs. 1994. Nonrandom chromosomal abnormalities in bovine lymphoma. Leuk. Res. 18:91-99.
26. Twizere, J. C., P. Kerkhofs, A. Burny, D. Portetelle, R. Kettmann, and L. Willems. 2000. Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo. J. Virol. 74:9895-9902.
27. Van den Broeke, A., Y. Cleuter, G. Chen, D. Portetelle, M. Mammerickx, D. Zagury, M. Fouchard, L. Coulombel, R. Kettmann, and A. Burny. 1988. Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells. Proc. Natl. Acad. Sci. USA 85:9263-9267.
28. Weinberg, R. A. 1989. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49:3713-3721.
29. Whitney, J. B., and R. M. Ruprecht. 2004. Live attenuated HIV vaccines: pitfalls and prospects. Curr. Opin. Infect. Dis. 17:17-26.
30. Willems, L., A. Burny, D. Collete, O. Dangoisse, F. Dequiedt, J. S. Gatot, P. Kerkhofs, L. Lefebvre, C. Merezak, T. Peremans, D. Portetelle, J. C. Twizere, and R. Kettmann. 2000. Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res. Hum. Retrovir. 16:1787-1795.
31. Willems, L., J. S. Gatot, M. Mammerickx, D. Portetelle, A. Burny, P. Kerkhofs, and R. Kettmann. 1995. The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads. J. Virol. 69:4137-4141.
32. Willems, L., C. Grimonpont, P. Kerkhofs, C. Capiau, D. Gheysen, K. Conrath, R. Roussef, R. Mamoun, D. Portetelle, A. Burny, E. Adam, L. Lefebvre, J. C. Twizere, H. Heremans, and R. Kettmann. 1998. Phosphorylation of bovine leukemia virus Tax protein is required for in vitro transformation but not for transactivation. Oncogene 16:2165-2176.
33. Willems, L., P. Kerkhofs, L. Attenelle, A. Burny, D. Portetelle, and R. Kettmann. 1997. The major homology region of bovine leukaemia virus p24gag is required for virus infectivity in vivo. J. Gen. Virol. 78:637-640.
34. Willems, L., P. Kerkhofs, F. Dequiedt, D. Portetelle, M. Mammerickx, A. Burny, and R. Kettmann. 1994. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc. Natl. Acad. Sci. USA 91:11532-11536.
35. Willems, L., R. Kettmann, F. Dequiedt, D. Portetelle, V. Voneche, I. Cornil, P. Kerkhofs, A. Burny, and M. Mammerickx. 1993. In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 67:4078-4085.
36. Willems, L., D. Portetelle, P. Kerkhofs, G. Chen, A. Burny, M. Mammerickx, and R. Kettmann. 1992. In vivo transfection of bovine leukemia provirus into sheep. Virology 189:775-777.
37. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
38. Wyand, M. S., K. H. Manson, A. A. Lackner, and R. C. Desrosiers. 1997. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nat. Med. 3:32-36.
39. Yoshida, M. 2005. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24:5931-5937.